Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BFCA Conditioning for Haploidentical HSCT in SAA
NCT03821987Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label, single-arm trial of fludarabine in aplastic anemia, sponsored by Peking University People's Hospital. Primary endpoint: 1 year cumulative incidence overall survival. Status: unknown.
02
Drugs
fludarabine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT03821987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03821987.